Osteoanabolics
Vishal Gupta, Mitul Abhaykumar Shah, Sagar Kirtibhai Shah and 1 more
Indian Journal of Endocrinology and Metabolism · 2012
doi:10.4103/2230-8210.95662 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Osteoporosis is characterized by reduced bone mass, impaired bone quality, and a propensity to fracture. An "osteoanabolic" should be referred to any therapy that helps increase bone mass. Bone mass represents 80% of bone mechanical strength. A low bone mass therefore provides the strongest association of future risk of fracture. This review aims to discuss all available and future therapies that attempt to increase bone mass be it organic or inorganic.
Abstract licence: CC BY-NC-SA
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.